RBM8A and glioblastoma: To examine how these effects of RBM8A on GBM cells in vitro may translate to clinical phenotypes, we injected U87-MG cells stably expressing RBM8A-KD1 shRNA or no shRNA intracranially into female nude mice and monitored GBM progression.